摘要
背景与目的:白介素37(IL-37)是一种抗炎t细胞反应的重要调节器。在这项研究中,我们研究了它的表达和功能在外周血单核细胞(PBMCs)HLA-B27相关急性前葡萄膜炎患者和特发性AAU(AAU)。方法:15 HLA-B27-associated AAU患者,10特发性AAU患者和22控制招募本研究从2013年8月到2016年12月。完整的眼科检查和临床特征显然是记录。血液样本收集和提取外周血单核细胞。IL-37信使核糖核酸(mRNA)和蛋白表达在外周血单核细胞(PBMCs)被执行rt - pcr和免疫印迹检测,分别。上层清液的细胞因子刺激树突细胞(dc)IL-37被多路复用免疫测定化验。结果:IL-37 mRNA和蛋白表达水平的增加PBMCs被发现在病人组与临床积极AAU相比控制。没有显著差异IL-37 mRNA和蛋白表达水平之间HLA-B27 AAU和特发性AAU有关。IL-37显著抑制生产IL-1β、il - 6、il - 10,IL-21,IL-23,TNF-αIFN-γ。IL-37 mRNA和蛋白表达水平与疾病活动呈显著正相关。结论:高架IL-37表达式与疾病相关联活动HLA-B27 AAU和特发性AAU有关。在AAU IL-37可以抑制促炎细胞因子产品。操纵IL-37可能为这些实体提供一个新的治疗目标。
关键词: 急性前葡萄膜炎、IL-37、细胞因子、HLA-B27特发性AAU PBMC。
Current Molecular Medicine
Title:Elevated Interleukin 37 Expression Associated With Disease Activity in HLA-B27 Associated Anterior Uveitis and Idiopathic Anterior Uveitis
Volume: 17 Issue: 7
关键词: 急性前葡萄膜炎、IL-37、细胞因子、HLA-B27特发性AAU PBMC。
摘要: Background & Objective: Interleukin 37 (IL-37) is an important regulator of the anti-inflammatory T-cell response. In this study, we investigated its expression and function in peripheral blood mononuclear cells (PBMCs) of patients with HLA-B27 associated acute anterior uveitis (AAU) and idiopathic AAU.
Methods: 15 patients with HLA-B27-associated AAU, 10 patients with idiopathic AAU and 22 controls were recruited to this study from August 2013 to December 2016. Complete ophthalmological examinations were performed and clinical features were clearly documented. Blood samples were collected and peripheral blood mononuclear cells were extracted. IL-37 messenger RNA (mRNA) and protein expression in peripheral blood mononuclear cells (PBMCs) were examined by performing RT-PCRs and western blot, respectively. Cytokines in the supernatants of stimulated dendritic cells (DCs) with IL-37 were assayed by multiplex immunoassay.
Results: An increased level of IL-37 mRNA and protein expression by PBMCs was found in the patient group with clinically active AAU compared to controls. There was no significant difference in IL-37 mRNA and protein expression levels between HLA-B27 associated AAU and idiopathic AAU. IL-37 significantly inhibited the production of IL-1β, IL-6, IL-10, IL-21, IL-23, TNF-α and IFN-γ. IL-37 levels of mRNA and protein expression showed a significant positive correlation with disease activity.
Conclusions: Elevated IL-37 expression is associated with disease activity in HLA-B27 associated AAU and idiopathic AAU. IL-37 can inhibit proinflammatory cytokine productions in AAU. Manipulation of IL-37 may offer a new therapeutic target for these entities.
Export Options
About this article
Cite this article as:
Elevated Interleukin 37 Expression Associated With Disease Activity in HLA-B27 Associated Anterior Uveitis and Idiopathic Anterior Uveitis, Current Molecular Medicine 2017; 17 (7) . https://dx.doi.org/10.2174/1566524018666180207152941
DOI https://dx.doi.org/10.2174/1566524018666180207152941 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Over-Expression, Solubilization, and Purification of G Protein-Coupled Receptors for Structural Biology
Combinatorial Chemistry & High Throughput Screening Patent Selections
Recent Patents on Drug Delivery & Formulation Reactive Oxygen Species as Intracellular Signaling Molecules in the Cardiovascular System
Current Cardiology Reviews Recent Advances in Molecular Hydrogen Research Reducing Exercise-Induced Oxidative Stress and Inflammation
Current Pharmaceutical Design Neuropeptides and Other Chemical Mediators, and the Role of Anti-inflammatory Drugs in Primary Headaches
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry subject Index To Volume 9
Protein & Peptide Letters Role of Molecular Hydrogen in Skin Diseases and its Impact in Beauty
Current Pharmaceutical Design Role of Angiotensin II in the Development of Nephropathy and Podocytopathy of Diabetes
Current Diabetes Reviews Protein Microarrays for Studies of Drug Mechanisms and Biomarker Discovery in the Era of Systems Biology
Current Pharmaceutical Design State-of-the-Art Magnetic Resonance Spectroscopy in Oncologic Imaging
Current Molecular Imaging (Discontinued) The Importance of NAD in Multiple Sclerosis
Current Pharmaceutical Design Rooteomics: The Challenge of Discovering Plant Defense-Related Proteins in Roots
Current Protein & Peptide Science A Review on Hematopoietic Stem Cell Treatment for Epilepsy
CNS & Neurological Disorders - Drug Targets Angiotensin-Converting Enzyme Inhibitors: Mechanisms of Action and Implications In Anesthesia Practice
Current Pharmaceutical Design Neuronal Generation from Somatic Stem Cells: Current Knowledge and Perspectives on the Treatment of Acquired and Degenerative Central Nervous System Disorders
Current Gene Therapy Endocannabinoid System: Emerging Role from Neurodevelopment to Neurodegeneration
Mini-Reviews in Medicinal Chemistry Prolactin Induces IL-2 Associated TRAIL Expression on Natural Killer Cells from Chronic Hepatitis C Patients <i>In vivo</i> and <i>In vitro</i>
Endocrine, Metabolic & Immune Disorders - Drug Targets Metabolites of Dietary Protein and Peptides by Intestinal Microbes and their Impacts on Gut
Current Protein & Peptide Science CRP and Anti-CRP Autoantibodies in Systemic Lupus Erythematosus
Current Rheumatology Reviews Development of personalized molecular therapy for acute myeloid leukemia
Current Pharmaceutical Biotechnology